Smoking Cessation Recommendation
This patient should receive varenicline combined with clinician counseling as the optimal smoking cessation strategy. 1, 2
Rationale for Varenicline Over Bupropion
Bupropion is absolutely contraindicated in this patient due to his history of seizures. 1, 3 Even though he no longer requires antiepileptic medications, the FDA label and NCCN guidelines explicitly state that bupropion is contraindicated in patients with any history of seizure disorder because it lowers the seizure threshold. 1, 3, 4 This contraindication applies regardless of how remote the seizure history is or whether the patient is currently on medication. 3
Varenicline, in contrast, has no such contraindication for seizure history and represents a safer first-line choice for this patient. 2, 5 The only absolute contraindication for varenicline is an allergy to the medication itself. 5
Why Combination Therapy (Varenicline + Counseling) is Essential
Pharmacotherapy alone is insufficient—behavioral counseling must be combined with medication to achieve optimal quit rates. 1, 2 The evidence is clear:
- Varenicline plus counseling achieves quit rates of 15.2% versus only 8.6% with brief advice alone. 2
- NCCN guidelines explicitly state that "pharmacotherapy regimens should always be paired with behavioral counseling." 1
- The combination approach addresses both the pharmacological addiction and the behavioral/psychological components of tobacco dependence. 1
Specific Treatment Protocol
Varenicline Dosing Schedule
- Begin varenicline 1-2 weeks before the target quit date (ideally 4-5 months before his hip replacement surgery). 1, 2
- Titration schedule: 1
- Days 1-3: 0.5 mg orally once daily
- Days 4-7: 0.5 mg orally twice daily
- Weeks 2-12: 1 mg orally twice daily (if tolerated)
- Treatment duration: Minimum 12 weeks, with consideration for an additional 12 weeks to maximize long-term abstinence. 1, 2
Counseling Requirements
- Minimum of 4 counseling sessions during the 12-week pharmacotherapy course. 2
- Each session should last 10-30+ minutes and include: 2
- Skills training for managing cravings
- Social support strategies
- Motivational interviewing techniques
- Addressing specific smoking triggers
Follow-Up Schedule
- First follow-up within 2-3 weeks after initiating varenicline to assess efficacy and tolerability. 1, 2
- Subsequent follow-up at 12 weeks and at therapy completion. 1, 2
- Long-term follow-up at 6 and 12 months to monitor for relapse. 1
Safety Considerations for This Patient
Cardiovascular Safety
Varenicline is safe in patients with stable cardiovascular disease and does not increase cardiovascular events or mortality. 6 This patient's controlled hypertension on hydrochlorothiazide is not a contraindication. 5
Common Side Effects to Monitor
- Nausea is the most common side effect (occurring in 16.3-41.9% of patients), but is generally manageable. 1, 7, 5
- If nausea is intolerable, dose reduction can be considered while maintaining efficacy. 8
- Monitor for neuropsychiatric symptoms (depression, suicidal ideation), though these are uncommon and varenicline was not found to increase these risks compared to placebo in recent large trials. 1
Expected Outcomes
Varenicline demonstrates superior efficacy compared to other monotherapies: 2, 7
- 6-month abstinence rates: 33.2% with varenicline versus 24.2% with bupropion SR
- Continuous abstinence rates at weeks 9-12 range from 43.9% to 65.4% with varenicline
- 52-week continuous abstinence rates range from 21.9% to 34.6% with varenicline
Critical Pitfalls to Avoid
- Never prescribe bupropion to patients with any seizure history, even if remote or controlled. 1, 3
- Never provide varenicline without concurrent behavioral counseling—this significantly reduces success rates. 1, 2
- Do not delay treatment initiation—begin now to allow adequate time before surgery. 2
- Do not discontinue therapy prematurely—complete the full 12-week course minimum. 1, 2
If Initial Treatment Fails
If the patient fails to achieve abstinence with varenicline plus counseling, the next step would be combination nicotine replacement therapy (NRT patch plus short-acting NRT for breakthrough cravings) with intensified behavioral therapy, or combining varenicline with NRT. 1